Jane Street
UTHR icon

Jane Street’s United Therapeutics UTHR Stock Holding History

Jane Street’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.8M Buy
146,300
+44,200
+43% +$22M 0.01% 714
2025
Q4 		$49.7M Hold
102,100
– – 0.01% 946
2025
Q3 		$42.8M Buy
102,100
+85,600
+519% +$28.8M 0.01% 1043
2025
Q2 		$4.74M Buy
16,500
+13,800
+511% +$4.12M ﹤0.01% 3073
2025
Q1 		$832K Buy
2,700
+1,400
+108% +$480K ﹤0.01% 5914
2024
Q4 		$459K Sell
1,300
-39,500
-97% -$14.5M ﹤0.01% 6957
2024
Q3 		$14.6M Sell
40,800
-437,300
-91% -$148M ﹤0.01% 1536
2024
Q2 		$152M Sell
478,100
-132,400
-22% -$35M 0.03% 272
2024
Q1 		$140M Buy
610,500
+605,700
+12,619% +$137M 0.03% 293
2023
Q4 		$1.06M Sell
4,800
-9,700
-67% -$2.24M ﹤0.01% 5473
2023
Q3 		$3.28M Buy
14,500
+10,400
+254% +$2.4M ﹤0.01% 3230
2023
Q2 		$905K Sell
4,100
-53,100
-93% -$11.8M ﹤0.01% 5354
2023
Q1 		$12.8M Sell
57,200
-1,600
-3% -$394K 0.01% 1385
2022
Q4 		$16.4M Buy
58,800
+22,400
+62% +$5.65M 0.01% 1157
2022
Q3 		$7.62M Sell
36,400
-32,100
-47% -$7.18M ﹤0.01% 2012
2022
Q2 		$16.1M Buy
68,500
+4,800
+8% +$976K 0.01% 1292
2022
Q1 		$11.4M Buy
63,700
+38,500
+153% +$7.33M ﹤0.01% 1827
2021
Q4 		$5.45M Buy
25,200
+4,700
+23% +$923K ﹤0.01% 2726
2021
Q3 		$3.78M Sell
20,500
-26,400
-56% -$5.2M ﹤0.01% 3214
2021
Q2 		$8.41M Buy
46,900
+29,500
+170% +$5.62M ﹤0.01% 1916
2021
Q1 		$2.91M Buy
17,400
+1,600
+10% +$267K ﹤0.01% 3313
2020
Q4 		$2.4M Sell
15,800
-3,000
-16% -$394K ﹤0.01% 3186
2020
Q3 		$1.9M Buy
18,800
+900
+5% +$98.8K ﹤0.01% 3122
2020
Q2 		$2.17M Buy
+17,900
New +$2.01M ﹤0.01% 2950
2017
Q4 		– Sell
-1,900
Closed -$223K – 5214
2017
Q3 		$223K Buy
+1,900
New +$243K ﹤0.01% 4018
2016
Q4 		– Sell
-1,900
Closed -$224K – 4649
2016
Q3 		$224K Buy
+1,900
New +$228K ﹤0.01% 3596

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Jane Street's UTHR Position: Q1 2026 in Review

Jane Street reduced its United Therapeutics (UTHR) stake by 99% in Q1 2026, selling an estimated $107M and leaving 2,759 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #5466.

Jane Street first reported a position in UTHR in Q3 2013 and has held it in 42 quarters since. The position peaked at $106M in Q4 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Jane Street held 2,759 shares of United Therapeutics worth $1.64M as of Q1 2026.
  • Jane Street sold 214,061 United Therapeutics shares in Q1 2026, an estimated $107M.
  • United Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #5466 holding.
  • Jane Street first reported a position in United Therapeutics in Q3 2013 and has held it in 42 quarters since.
  • Jane Street's United Therapeutics position peaked at $106M in Q4 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.